SCHEMBL5158047

SCHEMBL5158047

CCOc1cc(N)c(Cl)cc1C(=O)NCCN(CC)CC

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR4 Q13639 5/20 0.80
CYP2D6 P10635 4/20 0.80
CYP1A2 P05177 3/20 0.80
ADRA2A P08913 3/20 0.80
DRD3 P35462 3/20 0.80
DRD2 P14416 3/20 0.80
LMNA P02545 3/20 0.80
ALDH1A1 P00352 2/20 0.80
HTR3A P46098 2/20 0.80
HTR2B P41595 2/20 0.80
KCNH2 Q12809 2/20 0.80
HTR3E A5X5Y0 1/20 0.80
SLC22A1 O15245 1/20 0.80
HTR3B O95264 1/20 0.80
MPO P05164 1/20 0.80
ADRA2C P18825 1/20 0.80
DRD4 P21917 1/20 0.80
HTR2A P28223 1/20 0.80
HTR2C P28335 1/20 0.80
HTR3D Q70Z44 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9777127 0.90 HTR4 (0.79) HTR4CYP2D6CYP1A2ADRA2ADRD3
SCHEMBL9777134 0.90 HTR4 (0.76) HTR4CYP2D6CYP1A2ADRA2ADRD3
SCHEMBL9777097 0.90 HTR4 (0.76) HTR4CYP2D6CYP1A2ADRA2ADRD3
SCHEMBL9777166 0.90 HTR4 (0.76) HTR4CYP2D6CYP1A2ADRA2ADRD3
Metoclopramide SCHEMBL18629 0.89 HTR4 (1.00) HTR4CYP2D6CYP1A2ADRA2ADRD3
Metoclopramide SCHEMBL27855472 0.89 HTR4 (1.00) HTR4CYP2D6CYP1A2ADRA2ADRD3
Metoclopramide SCHEMBL28222039 0.89 HTR4 (1.00) HTR4CYP2D6CYP1A2ADRA2ADRD3
SCHEMBL9777123 0.89 CYP2D6 (0.74) HTR4CYP2D6CYP1A2ADRA2ADRD3
SCHEMBL9777161 0.89 HTR4 (0.78) HTR4CYP2D6CYP1A2ADRA2ADRD3
SCHEMBL9570884 0.89 CYP2D6 (0.74) HTR4CYP2D6CYP1A2ADRA2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771408-A4 METHOD FOR PREPARING 4-[2-(DIMETHYLAMINO)ETHOXY]BENZYLAMINE AS ITOPRIDE HYDROCLORIDE SALT MEDIATE IL YANG PHARM CO LTD (KR) 2007-08-29 EP disclosed
EP-1771408-A1 METHOD FOR PREPARING 4-[2-(DIMETHYLAMINO)ETHOXY]BENZYLAMINE AS ITOPRIDE HYDROCLORIDE SALT MEDIATE Il Yang Pharm. Co. Ltd. (KR) 2007-04-11 EP disclosed
WO-2006011696-A1 METHOD FOR PREPARING 4-[2-(DIMETHYLAMINO)ETHOXY]BENZYLAMINE AS ITOPRIDE HYDROCLORIDE SALT MEDIATE IL YANG PHARM. CO., LTD (KR) 2006-02-02 WO disclosed